|Bid||21.69 x 1200|
|Ask||29.55 x 800|
|Day's Range||21.40 - 21.92|
|52 Week Range||16.41 - 28.94|
|Beta (5Y Monthly)||1.72|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 15, 2023 - Feb 20, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||46.78|
LANCASTER, Pa., January 26, 2023--Emerald Advisers celebrated 30 years managing client funds in 2022 and is presenting the 30th Annual Groundhog Day Investment Forum on February 2nd.
The mean of analysts' price targets for Insmed (INSM) points to a 98.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The main aim of stock picking is to find the market-beating stocks. But every investor is virtually certain to have...